# Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.

> **NCT00418002** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 72 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AQW051

## Key facts

- **NCT ID:** NCT00418002
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2007-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418002, "Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00418002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*